Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Cytokine|January 19, 2016
Bacteria and genetically modified bacteria as cancer therapeutics: Current advances and challengesShreeram C Nallar, De-Qi Xu, Dhan V KalvakolanuCellular & Molecular Immunology|January 1, 2008
The interferon signaling network and transcription factor C/EBP-betaHui Li, Padmaja Gade, Weihua Xiao, et al.Translational Oncogenomics|May 14, 2011
GRIM-19: A Double-edged Sword that Regulates Anti-Tumor and Innate Immune ResponsesShreeram C Nallar, Sudhakar Kalakonda, Peng Sun, et al.Frontiers in Immunology|March 15, 2021
Perspectives on Oncolytic Salmonella in Cancer Immunotherapy-A Promising StrategyDing Wang, Xiaodong Wei, Dhan V Kalvakolanu, et al.Cytokine|May 6, 2018
Oncosuppressor protein p53 and cyclin-dependent kinase inhibitor p21 regulate interstitial cystitis associated gene expressionSusan Keay, Shreeram C Nallar, Padmaja Gade, et al.Clinical Epigenetics|March 5, 2022
Roles for the methyltransferase SETD8 in DNA damage repairLibo Xu, Ling Zhang, Jicheng Sun, et al.Experimental Cell Research|August 30, 2021
GRIM-19 inhibits proliferation and induces apoptosis in a p53-dependent manner in colorectal cancer cells through the SIRT7/PCAF/MDM2 axisDing Wang, Xiaodong Wei, Xuyang Chen, et al.Anti-Cancer Drugs|February 2, 2023
Stat3 shRNA delivery with folate receptor-modified multi-functionalized graphene oxide particles for combined infrared radiation and gene therapy in hepatocellular carcinomaXuyang Chen, Ling Zhang, Xiaoqin Wang, et al.Current Cancer Drug Targets|June 7, 2024
Low Expression of GRIM-19 Correlates with Poor Prognosis in Patients with Upper Urinary Tract Urothelial CarcinomaFeng Tian, Long Lv, Zonglin Liu, et al.Cytokine|March 27, 2019
IL-33 contributes to disease severity in Psoriasis-like models of mouseYaju Duan, Yonghua Dong, Hua Hu, et al.Pageof 4